The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Genomic copy number predicts esophageal cancer years before transformation
Open accessPublished version of a preprint
Abstract
Recent studies show that aneuploidy and driver gene mutations precede cancer diagnosis by many years 1-4. We assess whether these genomic signals can be used for early detection and pre-emptive cancer treatment using the neoplastic precursor lesion Barrett's esophagus as an exemplar 5. Shallow whole-genome sequencing of 777 biopsies, sampled from 88 patients in Barrett's esophagus surveillance over a period of up to 15 years, shows that genomic signals can distinguish progressive from stable disease even 10 years before histopathological transformation. These findings are validated on two independent cohorts of 76 and 248 patients. These methods are low-cost and applicable to standard clinical biopsy samples. Compared with current management guidelines based on histopathology and clinical presentation, genomic classification enables earlier treatment for high-risk patients as well as reduction of unnecessary treatment and monitoring for patients who are unlikely to develop cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the context of MGUS and SMM, these translocations still associate with high-risk genomic features,59,97,98 but strangely do not always predict progression as one might expect.9,90,99”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [99]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Integrated genomic characterization of oesophageal carcinoma
Sun, Q., Kelsen, D. P., Wiznerowicz, M., Lu, Y., Sandusky, G., Wan, Y., Weinhold, N., Wong, A. M., Carvalho, A. L., Luketich, J. D., et al. (2017) · Nature · doi:10.1038/nature20805 · Cited by 1,869
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Self-citationACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,498
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
Shaheen, N. J., Sharma, P., Overholt, B. F., Wolfsen, H. C., Sampliner, R. E., Wang, K. K., Galanko, J. A., Bronner, M. P., Goldblum, J. R., Bennett, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808145 · Cited by 1,434
Fitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y. S., Kang, J.-Y., Watson, P. J., Trudgill, N. J., Patel, P., Kaye, P., Sanders, S., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,344
Self-citation
Cited by
Sorted by citations
Items 101–149 of 149
van der Sluis, K., van Sandick, J. W., Koemans, W. J., van den Bosch, T., Broeks, A., Peters, D. D. G. C., Seignette, I. M., Rausch, C. R., van Dijk, E., Snæbjörnsson, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114981 · Cited by 1
Killcoyne, S., & Fitzgerald, R. C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01142-7 · Cited by 1
Self-citationCan Genomic Sequencing Identify High-Risk Barrett’s Esophagus Earlier Than Pathologists?
Stachler, M. D., & Bass, A. J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.10.020 · Cited by 1
The Utility of Biomarkers for Risk Stratification in Barrett’s Esophagus
Konda, V. J. A., & Ellison, A. C. (2021) · Foregut The Journal of the American Foregut Society · doi:10.1177/2634516121995027 · Cited by 1
Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract
Lechner, A., Kumbrink, J., Walz, C., Jung, A., Baumeister, P., & Flach, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1364958 · Cited by 1
Qian, P., Sun, J., Tao, Y., Mu, H., Liu, Y., & Lu, P. (2023) · Research Square · doi:10.21203/rs.3.rs-3494487/v1 · Cited by 1
Experimental evolution of cancer chromosomal changes
Guscott, M. A., & McClelland, S. E. (2024) · Nature Genetics · doi:10.1038/s41588-024-01742-6 · Cited by 1
Insurance coverage and patient outcomes: Understanding changes in esophageal cancer treatment
Mukundan, A., Nagisetti, Y., Karmakar, R., & Wang, H. C. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i7.107154 · Cited by 1
A genomic instability-based model for Barrett’s oesophagus progression
Romero, D. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00436-2
Corley, D. A., Peek, R. M., & Simpson, B. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.023
Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception
Garman, K. S. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.018
El aynara en el reflan djudeo-espanyol
Koén-Sarano, M. (2009) · AKI YERUSHALAYIM: Revista Kulturala Djudeo-espanyola
Esophageal dysbiosis and neoplasia: Moving from Barrett's esophagus to adenocarcinoma
Proaño-Vasco, A., & Quante, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95070-1.00013-8
Data from A View on Drug Development for Cancer Prevention
Reynolds, A. R., Moschetta, M., Yohannes, A. R., Walcott, F. L., Ashford, M. B., Szűcs, Z., Sarbajna, T., Hadfield, J., Harrison, E., Challis, B., et al. (2023) · doi:10.1158/2159-8290.c.6602824.v1
Data from A View on Drug Development for Cancer Prevention
Reynolds, A. R., Moschetta, M., Yohannes, A. R., Walcott, F. L., Ashford, M. B., Szűcs, Z., Sarbajna, T., Hadfield, J., Harrison, E., Challis, B., et al. (2023) · doi:10.1158/2159-8290.c.6602824
Zhang, Y., Dai, J., Wang, D., Zhou, J., Wang, S., Suo, C., & Chen, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3201014/v1
Chronic Inflammation and Carcinogenesis in Gastrointestinal Tract
Shimizu, T., Nakanishi, Y., & Seno, H. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.2167
Endoscopy and Endoscopic Ultrasound for Esophageal Cancer
Gowing, S. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-39086-9_4
Refining definitions of Barrett’s oesophagus to improve clinical resource utilisation
Stachler, M. D., & Ain, Q. U. (2024) · Gut · doi:10.1136/gutjnl-2023-331458
Barrett's Esophagus in Time and Space: A Methylation Panel for Tracking Esophageal Cancer
Jacobson, D. H., & Fitzgerald, R. C. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003378
Self-citationEmerging Biomarkers for Managing Barrett’s Esophagus
Rojanasopondist, P., Kaz, A. M., Yu, M., & Grady, W. M. (2025) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2025.05.005
Bartram, A., O’Donovan, M., Fitzgerald, R. C., & Katzka, D. A. (2025) · Foregut The Journal of the American Foregut Society · doi:10.1177/26345161251354937
Self-citationCurrent Concepts for Diagnosing Non-Dysplastic and Dysplastic Barrett’s Esophagus
Stachler, M. D., Metanat, Y., & Willis, J. E. (2025) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2025.05.007
Multi-omics profiling and molecular pathways in esophageal adenocarcinoma
Gao, Q., Xun, J., Liu, B., Jiang, X., Wang, Y., Zhang, Q., & Wu, Y. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102653
Ercan, C., Pan, X., Paulson, T. G., Stachler, M. D., Akarca, F. G., Grady, W. M., Maley, C. C., & Yuan, Y. (2026) · Cancer Research · doi:10.1101/2025.11.11.25339952
Lu, B., Curtius, K., Graham, T. A., Yang, Z., & Barnes, C. (2024) · Figshare · doi:10.6084/m9.figshare.26598512
Fu, Y., Agrawal, S., Snyder, D. R., Yin, S., Zhong, N., Grunkemeyer, J. A., Dietz, N., Corlett, R., Hansen, L. A., Al‐Refaie, W. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26758538
Lu, B., Curtius, K., Graham, T. A., Yang, Z., & Barnes, C. (2024) · Figshare · doi:10.6084/m9.figshare.26598509
Fu, Y., Agrawal, S., Snyder, D. R., Yin, S., Zhong, N., Grunkemeyer, J. A., Dietz, N., Corlett, R., Hansen, L. A., Al‐Refaie, W. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26517902
Fu, Y., Agrawal, S., Snyder, D. R., Yin, S., Zhong, N., Grunkemeyer, J. A., Dietz, N. E., Corlett, R., Hansen, L. A., Waddah, A.-R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26758541
Fu, Y., Agrawal, S., Snyder, D. R., Yin, S., Zhong, N., Grunkemeyer, J. A., Dietz, N. E., Corlett, R., Hansen, L. A., Waddah, A.-R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26517848
Fu, Y., Agrawal, S., Snyder, D. R., Yin, S., Zhong, N., Grunkemeyer, J. A., Dietz, N., Corlett, R., Hansen, L. A., Waddah, A.-R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26758535
Lu, B., Curtius, K., Graham, T. A., Yang, Z., & Barnes, C. (2024) · Figshare · doi:10.6084/m9.figshare.26598506
Lu, B., Curtius, K., Graham, T. A., Yang, Z., & Barnes, C. (2024) · Figshare · doi:10.6084/m9.figshare.26598515
Turkot, M. H., Yusuf, A., Nowicki-Osuch, K., Pilonis, N., Malhotra, S., O’Donovan, M., Mróz, A., Lenarcik, M., Wrońska, E., Mikuła, M., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.01.025
Self-citationBiomarker Use in Barrett's Esophagus Surveillance
Chatterjee, A., Abrams, J. A., & Stachler, M. D. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003949
SMAD4 loss drives chromosomal instability during tumourigenesis via translational reprogrammingPreprint
Milne, J. V., Wu, K., Kusnadi, E. P., Brosda, S., Fujihara, K. M., Mustafa, E. H., Witts, S., Papastratos, K., Pechlivanis, M., Trigos, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.23.712291
Wu, P., Lan, L., Li, Z., Shakir, I., Zhou, J., Yao, Y., Ying, B., Zhou, J., Sun, X., Li, Y., et al. (2026) · Small · doi:10.1002/smll.202514464
Monarrez, I., Kim, E. N., Moon, K., Baker, A. M., Chen, P. Z., Bressan, D., Miremadi, A., di Pietro, M., Hannon, G. J., Graham, T. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.08.723546
Self-citationPostendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions
Goyal, R., Codipilly, D. C., & Iyer, P. G. (2026) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001172
Biomarker-targeted therapies for advanced-stage esophageal cancer
Wang, W. J., Li, P., & Ling, Z. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45079
Zellenrath, P. A., Chan, M. W., Pouw, R. E., di Pietro, M., Lu, V. Y. Z., Koch, A. D., Honing, J., & Spaander, M. C. W. (2026) · npj Women s Health · doi:10.1038/s44294-026-00147-6
Improving risk stratification in Barrett’s esophagus – time to teach an old dog new tricks
Frei, N. F., & Borovicka, J. (2026) · Endoscopy · doi:10.1055/a-2898-6686
Wang, Z., Wu, W., Xu, Y., Zhu, Y., Liu, W., Zhou, Z., Yu, S., Li, C., & Shilinjun (2026) · Oral Oncology · doi:10.1016/j.oraloncology.2026.108102
Mechanisms underpinning the progression of nondysplastic Barrett's oesophagus to cancer
Derwa, Y. H., Lin, M., & McDonald, S. A. C. (2026) · FEBS Journal · doi:10.1111/febs.70685
Translational reprogramming drives chromosomal instability during tumorigenesisPreprint
Clemons, N. J., Milne, J. V., Wu, K. M., Kusnadi, E. P., Brosda, S., Fujihara, K., Mustafa, E. H., Witts, S., Papastratos, K., Pechlivanis, M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11070815/v1
Kamalumpundi, V., Hadjinicolaou, A. V., di Pietro, M., & Leggett, C. L. (2026) · Diseases of the Esophagus · doi:10.1093/dote/doag112
Protracted copy number alteration evolution in Barrett’s oesophagus leading to oesophageal cancerPreprint
Gabbutt, C., Fernández-Sanromán, Á., Grant, H. E., Milite, S., Cross, W. C. H., Wright, N. A., Maley, C. C., Sottoriva, A., Caravagna, G., Paulson, T. G., et al. (2026) · medRxiv · doi:10.64898/2026.10.16.26365037
Clonal cell states link gastroesophageal junction tissues with metaplasia and cancer
Gier, R. A., & Shaffer, S. M. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.16997177
Metadata
- Authors
- Killcoyne, S., Gregson, E., Wedge, D. C., Woodcock, D. J., Eldridge, M. D., de la Rue, R., Miremadi, A., Abbas, S., Blasko, A., Kosmidou, C., Januszewicz, W., Jenkins, A. V., Gerstung, M., & Fitzgerald, R. C.
- Affiliations
- European Bioinformatics Institute (GB)
- University of Cambridge (GB)
- University of Manchester (GB)
- University of Oxford (GB)
- Cancer Research UK (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Gerstung, Moritz
- Fitzgerald, Rebecca C.
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-09-07
- Volume
- 26
- Issue
- 11
- Pages
- 1726-1732
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC7116403
- OpenAlex
- W3083497411
- Cited by
- 149
- References
- 52
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 24 · 2023: 27 · 2022: 20 · 2021: 32 · 2020: 3
- FWCI
- 18.73
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Nature Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Funders
- United European Gastroenterology Research Prize, RG76026
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Barrett's esophagus, esophageal adenocarcinoma, cancer transformation, copy number alterations, early cancer detection, aneuploidy, genomic classification, cancer surveillance, preemptive therapy
- MeSH terms
- Whole Genome Sequencing, Aged, Aneuploidy, Barrett Esophagus, Biopsy, Esophageal Neoplasms, Female, Humans, Male, Middle Aged, Precancerous Conditions, Genome, Human, Genomics, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
